| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $3,760,586 ) |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AG102286 | AstroTarget™ Astro-Enrichment Kit: A Microfluidic-Free Platform for High-Throughput Rare-Astrocyte Isolation and Multi-Omic Profiling from Frozen Alzheimer’s Brain | 000 | 1 | NIH | 9/8/2026 | $506,495 |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AI195215 | HIVE-seq: A Novel Omics Technology to Profile Thousands of Single HIV-Positive Cells | 000 | 1 | NIH | 8/19/2026 | $307,074 |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AG091101 | FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues | 002 | 2 | NIH | 8/27/2026 | $1,012,648 |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44GM163514 | Integrated High-Throughput Microfluidic-Mass Spectrometry for Enhanced Biomedical Data Generation and AI Model Training | 000 | 1 | NIH | 8/4/2026 | $300,001 |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AI197850 | Spatially Resolved Single-Cell DNA Sequencing: A General Spatial Genomics Platform with Application to HIV Reservoir Mapping | 000 | 1 | NIH | 8/19/2026 | $299,991 |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44GM161309 | A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass Spectrometry | 000 | 2 | NIH | 8/20/2026 | $1,027,505 |
| | 2026 | 2026 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44CA310740 | Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic Development | 000 | 1 | NIH | 8/7/2026 | $306,872 |
| | 2026 | 2025 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AG091101 | FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues | 001 | 1 | NIH | 8/26/2026 | $0 |
| | 2026 | 2025 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AG091101 | FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues | 000 | 1 | NIH | 2/16/2026 | $0 |
| | 2026 | 2024 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43NS135703 | Single cell tri-omics: High coverage simultaneous profiling of DNA, RNA, and proteins in single cells | 000 | 1 | NIH | 6/4/2026 | $0 |
| | 2026 | 2024 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43AI181436 | Point-of-care viral load monitoring to support large-scale clinical testing of new HIV cure strategies | 000 | 1 | NIH | 5/26/2026 | $0 |
| | 2026 | 2023 | VIVID BIOINNOVATIONS, PBC | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R42GM143989 | A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution | 000 | 3 | NIH | 2/9/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $613,743 ) |
| | 2025 | 2025 | FLUID DISCOVERY, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44AG091101 | FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues | 000 | 1 | NIH | 9/12/2025 | $306,871 |
| | 2025 | 2025 | FLUID DISCOVERY, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R44GM161309 | A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass Spectrometry | 000 | 1 | NIH | 7/21/2025 | $306,872 |
|
| Issue Date FY: 2024 ( Subtotal = $536,284 ) |
| | 2024 | 2024 | FLUID DISCOVERY, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43NS135703 | Single cell tri-omics: High coverage simultaneous profiling of DNA, RNA, and proteins in single cells | 000 | 1 | NIH | 1/31/2024 | $268,142 |
| | 2024 | 2024 | FLUID DISCOVERY, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R43AI181436 | Point-of-care viral load monitoring to support large-scale clinical testing of new HIV cure strategies | 000 | 1 | NIH | 4/1/2024 | $268,142 |
|
| Issue Date FY: 2023 ( Subtotal = $817,050 ) |
| | 2023 | 2023 | FLUID DISCOVERY, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R42GM143989 | A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution | 000 | 3 | NIH | 9/19/2023 | $817,050 |
| | 2023 | 2021 | FLUID DISCOVERY, INC. | 953 INDIANA ST | SAN FRANCISCO | CA | 94107-3007 | SAN FRANCISCO | USA | R41GM143989 | Ultrahigh Throughput Microscale Mass Spectrometry for Pharmaceutical Prenylation Enzyme Engineering | 000 | 1 | NIH | 7/20/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $837,842 ) |
| | 2022 | 2022 | FLUID DISCOVERY INC | 42 LONGVIEW DR | DALY CITY | CA | 94015-4714 | SAN MATEO | USA | R42GM143989 | A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution | 000 | 2 | NIH | 9/16/2022 | $837,842 |
| | 2022 | 2021 | FLUID DISCOVERY INC | 42 LONGVIEW DR | DALY CITY | CA | 94015-4714 | SAN MATEO | USA | R41GM143989 | Ultrahigh Throughput Microscale Mass Spectrometry for Pharmaceutical Prenylation Enzyme Engineering | 000 | 1 | NIH | 12/10/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $253,795 ) |
| | 2021 | 2021 | FLUID DISCOVERY INC | 42 LONGVIEW DR | DALY CITY | CA | 94015-4714 | SAN MATEO | USA | R41GM143989 | Ultrahigh Throughput Microscale Mass Spectrometry for Pharmaceutical Prenylation Enzyme Engineering | 000 | 1 | NIH | 9/24/2021 | $253,795 |
|
|
